Sei Investments CO Invitae Corp Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $349,389 - $681,428	-23,768 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $40,792 - $56,380	-1,678 Reduced 6.59%	23,768 $676,000
Q2 2021 Aug 06, 2021	SELL	$26.09 - $40.4 $347,310 - $537,804	-13,312 Reduced 34.35%	25,446 $858,000
Q1 2021 May 12, 2021	SELL	$33.06 - $56.93 $14,215 - $24,479	-430 Reduced 1.1%	38,758 $1.53 Million
Q4 2020 Feb 08, 2021	SELL	$39.09 - $57.4 $139,746 - $205,205	-3,575 Reduced 8.36%	39,188 $1.64 Million

Q3 2020 Dec 04, 2020	SELL	$28.43 - $44.67 $21,322 - $33,502	-750 Reduced 1.72%	42,763 $1.85 Million
Q3 2020 Nov 06, 2020	BUY	$28.43 - $44.67 $271,193 - $426,107	9,539 Added 28.08%	43,513 $1.89 Million
Q2 2020 Aug 17, 2020	SELL	$11.71 - $30.29 $341,205 - $882,590	-29,138 Reduced 46.17%	33,974 $1.03 Million
Q2 2020 Aug 11, 2020	BUY	$11.71 - $30.29 $739,041 - $1.91 Million	63,112 New	63,112 $1.33 Million
Q1 2020 May 14, 2020	SELL	$7.64 - $27.5 $313,492 - $1.13 Million	-41,033 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$15.02 - $20.57 $63,910 - $87,525	4,255 Added 11.57%	41,033 $662,000
Q3 2019 Nov 12, 2019	BUY	$18.85 - $27.5 $51,517 - $75,157	2,733 Added 8.03%	36,778 $709,000
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $467,999 - $707,792	-26,943 Reduced 44.18%	34,045 $800,000
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $649,522 - $1.57 Million	60,988 New	60,988 $1.43 Million
Q4 2018 Feb 13, 2019	SELL	$9.26 - $16.38 $99,415 - $175,855	-10,736 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$7.54 - $18.31 $80,949 - $196,576	10,736 New	10,736 $138,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account